Antibody class defines function in B cell immunity, but how class is propagated into B cell memory remains poorly understood. Here we demonstrate that memory B cell subsets unexpectedly diverged across antibody class through differences in the effects of major transcriptional regulators. Conditional genetic deletion of the gene encoding the transcription factor T-bet selectively blocked the formation and antigen-specific response of memory B cells expressing immunoglobulin G2a (IgG2a) in vivo. Cell-intrinsic expression of T-bet regulated expression of the transcription factor STAT1, steady-state cell survival and transcription of IgG2a-containing B cell antigen receptors (BCRs). In contrast, the transcription factor RORa and not T-bet was expressed in IgA + memory B cells, with evidence that knockdown of RORa mRNA expression and chemical inhibition of transcriptional activity also resulted in lower survival and BCR expression of IgA + memory B cells. Thus, divergent transcriptional regulators dynamically maintain subset integrity to promote specialized immune function in class-specific memory B cells. 5, 6 . However, little is known about the molecular signals required for the survival, activation or differentiation of class-switched memory B cells. Several studies have delineated how cytokines affect transcriptional programs differently in naive B cells that culminate in class-switch recombination 7, 8 . Interleukin 4 (IL-4) and interferon-γ (IFN-γ) reciprocally regulate class switching to IgG1 and IgG2a 7 , whereas the ability to express TGFβRII, the type II receptor for the cytokine TGF-β (transforming growth factor-β), in naive B cells is required for switching to IgA 9 . However, it remains to be studied whether programmatic differences initiated at the time of class switching extend into memory B cell compartments to control longevity, cell fate and memory B cell function in an antibody class-specific manner.
Memory B cells are long-lived antigen-experienced B cells that typically express a high-affinity B cell antigen receptor (BCR), rapidly expand their populations and differentiate into plasma cells after antigen rechallenge 1, 2 . Although memory B cells that express immunoglobulin M (IgM) have specialized functions 3 , many antigen-primed B cells switch to non-IgM isotypes under the antigen-specific regulation of follicular helper T cells 4 . Furthermore, non-IgM classes of membranebound antibody have different abilities to transduce signals through their BCR on the basis of the constant region expressed 5, 6 . However, little is known about the molecular signals required for the survival, activation or differentiation of class-switched memory B cells. Several studies have delineated how cytokines affect transcriptional programs differently in naive B cells that culminate in class-switch recombination 7, 8 . Interleukin 4 (IL-4) and interferon-γ (IFN-γ) reciprocally regulate class switching to IgG1 and IgG2a 7 , whereas the ability to express TGFβRII, the type II receptor for the cytokine TGF-β (transforming growth factor-β), in naive B cells is required for switching to IgA 9 . However, it remains to be studied whether programmatic differences initiated at the time of class switching extend into memory B cell compartments to control longevity, cell fate and memory B cell function in an antibody class-specific manner.
The differentiation of effector cells of the immune system relies heavily on transcription factors that belong to the following three families: T-box, GATA and ROR 10 . Members of all three families share the ability to directly interact with chromatinremodeling machinery to transactivate or repress gene targets in a cell context-dependent manner. Transcriptional regulators from each family induce molecular programs known to direct cells of the immune system into functional subsets [11] [12] [13] . T-bet, a member of the T-box family, has a critical role in inducing IFN-γ production by T helper type 1 (T H 1) cells, natural killer (NK) cells and CD8 + cells to regulate antiviral immunity 12 . T-bet expression by naive B cells is sufficient to promote class switching to IgG2a and is required for IFN-γ-induced production of IgG2a in vivo 14, 15 . In contrast, members of the GATA family are expressed by T H 2 cells, basophils and mast cells and are crucial to IL-4 production and immunity to helminthes 13 . Although members of the ROR family are less well characterized, RORγt and RORα are present in cells of the T H 17 subset of helper T cells 16 and are known to be involved in mucosal immunity to extracellular bacteria 11 . Although factors that belong to these families have been well characterized in several subsets of cells of the immune response, their roles in memory B cell development and the regulation of memory B cell function remain unknown.
Here we focus on IgG2a + and IgA + memory B cells and provide evidence for the divergent programming of memory B cell function by the major transcriptional regulators T-bet and RORα. Temporal deletion of T-bet in IgG2a + memory B cells established a central and selective role for this regulator in the survival and antigen responsiveness of IgG2a + memory B cells in vivo. Differences in the expression of cytokine receptors, integrins and RORα highlighted the specialized development and unique properties of IgA + memory B cells. Notably, a role for both T-bet and RORα in persistent BCR transcription indicated both dynamic and ongoing class-specific requirements for each of these factors in IgG2a + and IgA + memory B cells, respectively. Thus, we propose that expression of any non-IgM antibody signifies a transcriptionally regulated commitment event across subspecialized, class-specific memory B cells.
RESULTS

IgG2a memory formation requires T-bet in B cells
To look for class-specific transcriptional programs, we first focused on IgG2a + memory B cells, given evidence that B cell-intrinsic expression of T-bet is sufficient to induce germline IgG2a transcripts 15 . Furthermore, IFN-γ provided by CD8 + T cells transferred from OT-I mice (which have transgenic expression of an ovalbuminspecific T cell antigen receptor) skews B cells toward IgG2a class switching in vivo in ways dependent on non-T cell expression of T-bet 14 . To address the B cell-intrinsic requirement for T-bet in IgG2a class switching more directly and in polyclonal mice, we used mice with germline deletion of the gene encoding T-bet (Tbx21 −/− mice) 17 . These mice have defects in multiple cell types 12 , including defects in serum IgG 15 . Consistent with those characteristics, Tbx21 −/− mice had significantly fewer IgG3 + , IgG2a + and IgG2b + class-switched (IgM − IgD − ) CD38 hi B cells (also CD19 + B220 + CD138 − ) than did wild-type mice with intact IgG1 + B cells (Fig. 1a and Supplementary  Fig. 1) . Thus, the development of these putative memory B cell subsets was compromised in the absence of T-bet with no direct or indirect requirement for T-bet in IgG1 memory development.
To provide Tbx21 −/− B cells a source of wild-type polyclonal T cell help, we generated mixed peripheral chimeras deficient in recombination-activating gene 1 (Rag1 −/− ) given equal numbers of wild-type and Tbx21 −/− spleen cells (Fig. 1b) . After immunization of the recipient mice with the hapten NP-KLH (nitrophenylacetylkeyhole limpet hemocyanin), both wild-type and Tbx21 −/− B cell compartments produced robust class-switched NP-specific B cell responses (Fig. 1c) . Notably, the antigen-specific IgG2a + B cell response was >95% lower (Fig. 1d) and extended across antigen-specific germinalcenter (GC; CD38 lo ), memory (CD38 hi ) B cell (Supplementary Fig. 2a ) and plasma-cell (CD138 hi ; Fig. 1e ) compartments in the B cellspecific absence of T-bet. In contrast, slightly higher IgG1 + NP-specific B cell responses were induced in both donor populations ( Fig. 1d) with similar distribution into GC, memory B cell ( Supplementary  Fig. 2a ) and plasma-cell (Fig. 1e) compartments. We found no defects in IgG3 + or IgG2b + NP-specific B cell compartments in the absence of T-bet (Supplementary Fig. 2b) . Furthermore, total class-switched B cells, which would contain the KLH-specific response and polyclonal reactivities in the peripheral chimeras, showed a similar selective defect in IgG2a, with numbers in IgG1, IgG3 and IgG2b B cell compartments equivalent to those of wild-type mice ( Supplementary  Fig. 3) . Therefore, B cell-intrinsic expression of T-bet was required selectively for class switching to IgG2a and/or the survival of IgG2a + B cells after class switching in vivo.
Survival and function of IgG2a + memory B cells require T-bet
To enable analysis of T-bet expression in IgG2a + B cells after class switching, we crossed mice with loxP-flanked Tbx21 alleles (Tbx21 F/F mice) 18 to C57BL/6 mice with tamoxifen-inducible sequence encoding Cre recombinase in the ubiquitously expressed Rosa26 locus (Rosa26-CreER T2 mice). Treatment of the intact progeny (called 'CreER T2 Tbx21 F/F mice' here) with 4-hydroxy tamoxifen (4-OHT) induced the loss of T-bet protein in >50% of T-bet-expressing splenocytes (Fig. 2a) . Treated mice had a similarly lower number of IgG2a + B cells in with no change in the number of IgG1 + B cells. Notably, all remaining IgG2a + B cells had expression of T-bet protein (Fig. 2b) equivalent to that of treated CreER T2 Tbx21 +/+ mice (data not shown). Thus, ablation of Tbx21 in vivo led to substantial loss of IgG2a + memory B cells over 4 d with no exogenous stimulation of the BCR.
As temporal deletion with 4-OHT in vivo targets all cells, we sought to determine whether B cell-specific loss of T-bet had caused the (Fig. 2c,d and Supplementary Fig. 4a ). We treated splenocytes from donors of each genotype in vitro for 1 h with 4-OHT. This treatment resulted in excision of >90% of the Tbx21 F/F alleles ( Supplementary  Fig. 4b ) and provided a control, in wild-type cells, for the toxicity of this treatment. We transferred each set of treated cells into separate Rag1 −/− recipient mice together with T-bet-sufficient splenocytes from wild-type congenic mice immunized with NP-KLH. We then challenged the resultant mixed peripheral chimeras 24 h later with soluble antigen without adjuvant (which was unable to induce a primary NP-specific response; data not shown) to promote a secondary NP-specific B cell response in the recipient mice. Both Tbx21 F/F and Tbx21 +/+ 4-OHT-treated sources of NP-specific B cells induced secondary responses to soluble antigen with equivalent numbers of NPbinding CD138 − B220 + B cells and plasma cells (Fig. 2e) . However, the NP-specific IgG2a + recall response required T-bet, with <5% of Tbx21 F/F B cells responding after 4-OHT treatment relative to the number of responding wild-type B cells (Fig. 2f ) . The NP-specific IgG1 response remained intact and emerged to an extent equivalent to that in the absence of T-bet (Fig. 2f ) . We noted the same trends across the IgG2a + and IgG1 + plasma-cell compartments (Fig. 2f ).
We constructed mixed chimeras 6 months after the initial priming of donor mice and found the same selective loss of IgG2a + NP-specific cells after transfer and immunization ( Supplementary Fig. 4c ). 
A r t i c l e s
Thus, IgG2a + memory B cells selectively required B cell-intrinsic expression of T-bet to respond effectively to antigen rechallenge in vivo.
T-bet persists during the development of IgG2a + memory B cells Next we assessed changes in Tbx21 expression over the course of a primary and memory response in mice immunized with NP-KLH 19, 20 ( Fig. 3a) . Differences in the expression of CD138, B220 and CD38 on class-switched (IgM − IgD − ) antigen-binding (NP + ) CD19 + B cells provided direct access to IgG2a + B cells (Fig. 3b) . We used expression of the transcription factors Bcl-6 (ref. 21 ) and Blimp-1 (ref. 22) , together with that of antibody-isotype and phenotypic markers, to further distinguish the pre-GC stage (day 7; B220 hi CD38 hi Bcl-6 lo ), GC stage (days 7 and 14, primary; B220 hi CD38 lo Bcl-6 hi ), memory stage (day 14, primary; days 5 and 14, secondary; B220 hi CD38 hi Bcl-6 lo ) and plasma-cell stage (CD138 hi Blimp-1 hi ) of the antigenspecific development of IgG2a + memory B cells (Fig. 3c) . As anticipated, primary antigen-responsive IgG2a + B cells had abundant expression of T-bet before entry into GCs, which decreased substantially in the presence of Bcl-6 in GCs at days 7 and 14 after priming (Fig. 3d) . The immunization used here, based on an agonist of Toll-like receptor 4, promoted negligible IgM + memory B cells, with most NP-specific memory B cells expressing immunoglobulins of the IgG isotype (data not shown). After antigen rechallenge, NP-specific IgG2a + memory B cells had higher expression of T-bet that remained high for at least 14 d after recall (Fig. 3d, right) . In the presence of Blimp-1, IgG2a + plasma cells from all stages of the primary and memory response had low but detectable expression of T-bet (Fig. 3d,  left) . Thus, T-bet was expressed early after the initiation of class switching to IgG2a and continued to be expressed at all stages of antigenspecific IgG2a + memory B cell development and responses in vivo.
T-bet activity in IgG2a + memory B cells As evidence of T-bet activity in antigen-specific IgG2a + CD38 hi memory B cells, transcription of a series of genes known to be targets of T-bet 23 was higher at day 5 of the memory response in C57BL/6 wildtype mice immunized with adjuvant and NP-KLH (Fig. 4a, top) . The differences in the expression of these target genes indicated that T-bet enabled separate functions in IgG2a + memory B cells and naive B cells. Studies have shown that Bcl-6 can directly bind to T-bet and repress the expression of T-bet target genes in T cells 24 . To determine whether a similar event occurs in B cells, we assayed those same T-bet target genes in GC B cells with a greater abundance of Bcl-6 and found that their expression was lower in those cells than in memory B cells (Fig. 4a, bottom) . Furthermore, Blimp-1 has been shown to directly antagonize T-bet expression 25 . Plasma cells with a greater abundance of Blimp-1 protein had lower expression of most of the T-bet target genes assessed than did memory B cells or GC B cells (Fig. 4b) . Although T-bet activity was present in IgG2a + memory B cells, expression of Bcl-6 or Blimp-1 resulted in much less T-bet activity in IgG2a + GC B cells or IgG2a + plasma cells, respectively.
T-bet protein has broad expression across most IgG2a + CD38 hi memory B cells, with low but detectable expression in IgG1 + CD38 hi memory B cells (Fig. 4c) . At the single-cell level, most IgG2a + CD38 hi memory B cells had intermediate expression of T-bet mRNA, with a minor fraction having substantial expression per cell (Fig. 4d) . As anticipated on the basis of the population analysis, many of the T-bet-expressing memory cells also had detectable expression of IFN-γ mRNA. Thus, it is likely that IgG2a + memory B cells are a source of IFN-γ in vivo.
The BCR-driven IgG2a response requires T-bet expression As IgM + memory B cells were not actively excluded from the experiments described above, we purified IgG2a + B cells from unimmunized CreER T2 Tbx21 F/F mice and treated the cells with 4-OHT in vitro. We transferred those treated IgG2a + memory B cells into Rag1 −/− recipients and reactivated them through their BCR with antibody to IgG2a (anti-IgG2a). This in vivo stimulus induced robust production of IgG2a + plasma cells with negligible numbers of CD19 + non-plasma cells remaining 4 d after transfer (Fig. 5a) . Nevertheless, after treatment with 4-OHT, there were 75% fewer IgG2a + plasma cells with no expansion of the residual CD19 + B cell compartment. Although cell recovery was low, we noted similar trends in a second series of experiments after sorting NP-specific memory B cells from immunized CreER T2 Tbx21 F/F mice, treating the cells with 4-OHT in vitro, transferring the cells into Rag1 −/− recipient mice and rechallenging the recipient mice with antigen ( Supplementary Fig. 5 ). Furthermore, we noted IgG2a-selective defects in total classswitched B cells with this experimental design (data not shown). 
Thus, B cell-intrinsic T-bet was required for the differentiation of plasma cells driven by the IgG2a-containing BCR in vivo.
Transcription factor STAT1, survival and IgG2a require T-bet To examine how T-bet exerted its effect on the fate of IgG2a + B cells, we used IgG1 + and IgG2a + memory B cells from wild-type or CreER T2 Tbx21 F/F mice for in vitro studies. Deletion of Tbx21 with 4-OHT in vitro resulted in a significant loss of transcription of the gene encoding STAT1 (the signal transducer of IFN-γ) selectively in IgG2a + B cells and not IgG1 + B cells, on a per-cell basis (Fig. 5b, left) . In the absence of T-bet, there was also a small but significant effect on cell survival in short-term cultures in the presence of the transcription factor BAFF, with a loss of IgG2a + B cells and more IgG1 + B cells (Fig. 5b, middle) . However, over the same period, there was a loss of >75% in mature transcripts encoding the IgG2a constant region on a per-cell basis (Fig. 5b, right) . Secondary culture on plates coated with anti-BCR induced a significant number of B cell blasts over 48 h in vitro, whereas IgG2a + B cells remained small, as assessed by forward scatter, in the absence of T-bet (Fig. 5c) . We selected small live cells for quantitative PCR analysis of mature transcripts encoding the IgG2a constant region and detected exaggerated losses in the absence of T-bet (Fig. 5c, right) . Thus, in the absence of T-bet in vitro, downregulation of the IgG2a-containing BCR and loss of Stat1 transcription were more pronounced than was the overall loss of IgG2a + memory B cells.
Next we investigated the IgG2a + B cell compartment in a mouse strain with a phosphorylation defect that prevents translocation of STAT1 to the nucleus (the 'Domino' mutation of Stat1, induced by N-ethyl-N-nitrosourea) 26 . Although T-bet expression was 50% lower in those mice than in wild-type mice, there was an almost complete loss of IgG2a + B cells (Fig. 5d) with a compensatory greater abundance of IgG1 + B cells in these mice (Fig. 5e, left) . Both trends become (Fig. 5e, right) . Thus, both T-bet expression and STAT1 activation seemed necessary for continued expression of the IgG2a-containing BCR and/or survival of IgG2a + memory B cells in vivo.
Separable programs for IgA + and IgG2a + memory B cells IgA has a dominant role at mucosal surfaces, binding to a variety of cells of the innate immune response, enhancing phagocytosis and triggering the local release of cytokines and inflammatory mediators 27, 28 . Expression of TGFβRII by B cells is required for class switching to IgA 9 , with some evidence for the involvement of T H 17 cells in the coordination of mucosal IgA responses 29 . Transcription factors of the Runx and Smad families have been shown to promote IgA-specific germline transcripts as precursors for class switching to IgA 8, 30 . To compare the transcriptional programs of IgG2a + versus IgA + memory B cells, we isolated isotype-switched (IgM − IgD − ) CD38 + B cells (also CD19 + CD138 − B220 + ) that were largely Ki67 − (noncycling) as quiescent memory B cell compartments from spleen or Peyer's patches (Fig. 6a,b) . IgG2a + memory B cells had higher expression of the interferon receptors IFN-γRI and IFN-γRII than did IgA + memory B cells. In contrast, IgA + memory B cells had higher expression of the interleukin receptors IL-17Rc and IL-22Rα2 than did IgG2a + memory B cells, which suggested differences in the responsiveness of these cells to IL-17 and IL-22 (Fig. 6c) . Furthermore, whereas both memory subsets had similar expression of TGFβR, IgA + memory B cells had higher expression of TGF-β signaling intermediates of the Smad family (Smad2, Smad3 and Smad4) and the TGF-β-associated adaptor Daxx (Fig. 6c) . IgG2a + memory B cells had the highest expression of the chemokine receptor CXCR3, whereas most IgA + memory B cells had the highest expression of integrin α 4 β 7 (Fig. 6d) . These data suggested that IgG2a + memory B cells and IgA + memory B cells had separable growth factor requirements, signaling propensity and tissue-homing potential (Supplementary Fig. 6 ).
Survival and BCR expression in IgA + memory cells require RORa Among the main transcription factors downstream of TGF-β and IL-17 signaling, RORα had higher expression in IgA + memory cells than in other memory and naive B cells (Fig. 7a) . GATA-3, Foxp3 and RORγt were detectable only in small amounts in naive B cells and IgG1 + , IgG2a + and IgA + memory B cells. Germline deletion of the gene encoding RORα in mice produces a complex phenotype with neurological defects and early death 31 . Hence, to probe the function of RORα in IgA + memory B cells, we silenced RORα expression in normal IgA + B cells through the use of small interfering RNA (siRNA) targeting RORα. We transfected whole mesenteric lymph nodes and Peyer's patch cells with RORα-specific siRNA by nucleofection, which resulted in ~50% less RORα mRNA after 4 d of culture in vitro than that in cells transfected with control siRNA (Fig. 7b, left) . This degree of RORα knockdown resulted in ~50% less mature IgA mRNA in the total cell population (Fig. 7c) . IgA + memory B cells isolated from these cultures had >80% less mature IgA BCR transcripts on a per-cell basis than did those transfected with control siRNA (Fig. 7b) . Thus, we found that IgA + B cells expressed RORα, along with evidence that it controlled dynamic BCR expression.
To interfere with the function of ROR proteins, we used SR1001, which inhibits the transcriptional activity of RORα and RORγt 32 . The presence of this functional inhibitor resulted in selectively fewer IgA + memory B cells that survived in culture for 6 d, without affecting IgG1 + B cells (Fig. 7c) . To establish the influence of this inhibitor on IgA + memory B cells, we treated purified IgA + memory B cells with SR1001 over short-term culture. As this drug inhibits only protein function, there was no significant effect on the expression of RORα mRNA (Fig. 7d, right) . However, there was significantly less transcription of the known RORα target genes encoding the inositol triphosphate receptor ITPR1 and the transcription factor HIF-1α. Notably, there was a significantly lower abundance of mature transcripts encoding the IgA-containing BCR per cell (Fig. 7d) . Thus, we found that RORα affected the function of IgA + memory B cells, along with evidence that it was required for the survival of IgA + B cells and control of transcription of mRNA encoding the IgAcontaining BCR.
DISCUSSION
Antigen-specific B cell memory is central to long-term immunoprotection and develops across many different antibody classes. Here we focused on unique properties of IgG2a + and IgA + memory B cells to demonstrate that divergent transcriptional regulators maintain class-specific integrity of memory B cell subsets. Both T-bet and RORα regulated the transcription of mature BCRs, which seemed necessary for the survival of IgG2a + and IgA + memory B cells, respectively. In addition, we used conditional genetic models with temporal deletion of T-bet to demonstrate defects in the ability of IgG2a + memory B cells to respond to antigen. Both IgG2a + A r t i c l e s and IgA + memory B cells expressed molecules of different transcriptional programs that reflected separate potentials for cytokine secretion, trafficking and survival that permitted flexibility in long-term antigen-specific immunoprotection. We propose that the events that lead to class switching after antigen experience lead to the 'imprinting' of molecular programs whose persistence is essential for maintaining the identity of memory B cell subsets.
The dynamic regulation of BCR transcription was a common component of both the RORα and T-bet programs. We found consensus binding sites for both transcription factors in the immunoglobulin 3′ regulatory region known to control class switching and antibody secretion 33 . Thus, separable T-bet-and RORα-dependent transcriptional programs in IgG2a + and IgA + memory B cells also controlled the central recognition properties of antigenspecific B cell memory.
Cognate follicular helper T cells (T FH cells) regulate many facets of the development of antigen-specific memory B cells 4 . Bcl-6 programs the development of T FH cells and their movement to B cell areas for cognate control of B cell immunity 34 . Cytokine production occurs in those follicular regions after contact with antigen-primed B cells in ways that can initiate antibody class switching 35 . In GCs, contact with T FH cells 36 regulates the clonal composition of GC B cells and export into B cell memory compartments 37 . In GC B cells, Bcl-6 can antagonize the function of T-bet, and this dynamic molecular interaction may underpin the fate of GC B cells and the development of IgG2a + memory B cells. There is evidence of cytokine-producing GC T FH cells that engage GC B cells in an antibody class-specific manner 35 . In this scenario, antibody class-specific regulation by cognate T FH cells may streamline affinity maturation and efficiently promote the development of memory B cells.
T-bet regulates critical functions in IgG2a + memory B cells. In naive T cells, signaling through the antigen receptor acts in synergy with IFN-γ-induced activation of STAT1 to promote initial T-bet expression 12 . We found a similar regulatory axis dependent on IFN-γ, STAT1 and T-bet in IgG2a + memory B cells. Ablating T-bet expression interfered with this program, which resulted in downregulation of BCR transcription and loss of IgG2a + memory B cells. Although the binding of antigens by memory BCRs is not required for survival 38 , we propose that memory B cells rely on tonic signaling through the BCR for survival, as do naive B cells 39 . Similar to antigen-specific plasma cells 20 , memory B cells may also retain antigen-presenting ability for extended periods in vivo. In this manner, continued BCR expression may also indirectly permit ongoing local contact with antigen-specific T FH cells 40 .
T-bet activity establishes a molecular framework that governs the functions of IgG2a + B cells. Although T-bet binds to target promoters regardless of cell type, its ability to transactivate and remodel loci is dependent on cell context 23 . The regulation of genes by T-bet is also coupled to the dynamic expression of its molecular antagonists Bcl-6 and Blimp-1 (refs. 24,25) . Notably, T-bet can assort asymmetrically in T cells at cell division 41 , and Bcl-6 has been shown to assort unevenly across GC B cells 42 . Our studies have shown that coexpression of Bcl-6 with T-bet in GC B cells resulted in repression of the transcription of T-bet targets. However, rather than abolishing a T-betdefined subset, Bcl-6 transiently and reversibly altered programming of IgG2a to allow productive GC activity and the development of IgG2a + memory B cells.
RORα, like T-bet, is able to recruit chromatin-remodeling machinery and directly transactivate loci 11 . However, unlike the interactions of T-bet, the interactions of RORα with Bcl-6 and Blimp-1 have not been characterized. Although some studies have indicated Bcl-6 represses RORγt and T H 17 differentiation 43, 44 , its cell-intrinsic effects on RORα remain unknown. Expression of RORα is required during early development 11 ; hence, mice deficient in RORα have severe developmental defects and die early. Studies of RORα targets in cells of the immune system have provided connections to the activation of IL-17, IL-17F, IL-22 and the receptor IL-23R (ref. 45) , and the repression of IL-6 and tumor necrosis factor 46 . It is unknown whether activation of these targets is direct or indirect, and we found no difference in the expression of these targets in IgA + memory B cells (data not shown). However, RORα is involved in several other pathways, including calcium signaling, circadian rhythm and cellular metabolism 11 , and there is evidence of an effect of SR1001 on ITPR1 and HIF-1α that might indicate other pathways in which IgA + memory B cells may be unique relative to other classes.
Antigen-specific memory B cell responses may also require subspecialized regulatory programs organized by antibody class. After antigen rechallenge, memory B cells need cognate T cell help to expand their populations and differentiate into plasma cells 47 . IgM + memory B cells have functions and an ability to respond that are different from those of their IgG + counterparts 3, 48 . Downstream antibody classes engage signaling pathways different from those engaged by IgM based on expression of the constant region of the BCR 5, 6 . Other class-specific memory B cell properties control migration; for example, T-bet drives IgG2a + memory B cells to inflammatory sites via CXCR3 expression, and the integrin α 4 β 7 guides IgA + memory cells to mucosal tissues 27 . Enhanced transcription of STAT1 and IFN-γR may uniquely sensitize IgG2a + memory B cells to IFN-γ signals. Similarly, RORα can enhance the sensitivity of cells to calcium 49 , and the calcium-dependent kinase CamKIV can enhance RORα expression 50 . Those types of changes in IgA + memory B cells may lower BCR-activation thresholds in a class-specific manner. Therefore, many attributes of class-specific B cell memory that are introduced after development may be further reinforced after antigen recall under the cognate guidance of memory T FH cells 40 .
Memory B cells are generally considered functionally equivalent, differing only by the antibody isotype they express. Here we have unexpectedly shown that B cell memory was organized in classspecific subsets, each with separate central transcriptional regulators. Specifically, the transcriptional regulators T-bet and RORα controlled divergent IgG2a + memory B cell subsets and IgA + memory B cell subsets, respectively, to control separate functions in these unique class-specific memory B cell compartments. T-bet is used by many cell types in response to inflammatory stimuli, with a focus on the clearance of intracellular pathogen 12 . We have now shown that IgG2a + B cell memory also relied selectively on a T-bet-dependent program to establish and maintain subset integrity. Similarly, IgA + B cell memory is specialized to protect the mucosal surfaces 27 , and the selective use of transcriptional regulator RORα enhances this unique memory B cell function. Notably, these unique developmental programs can be exploited for directed immunotherapeutic applications, the future formation of class-skewing vaccines, and the treatment of cancer and autoimmunity.
METHODS
Methods and any associated references are available in the online version of the paper.
